A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Erectile Dysfunction
Interventions
DRUG

sildenafil citrate

Tablets, 50mg and 100mg , Medication will be taken orally with a glass of water approximately one hour (30 min to 4 hours) before sexual activity. Subjects are to take one dose in any calendar day.Eligible patients fulfilling all inclusion/exclusion criteria will be assigned at Visit 2/Week 0 (Baseline) to receive sildenafil 50 mg as needed (PRN) during the first two weeks, and,thereafter, at Visit 3/Week 2, all enrolled subjects will be up titrated to sildenafil 100 mg PRN for the following four weeks.

Trial Locations (9)

11520

Pfizer Investigational Site, México

11850

Pfizer Investigational Site, México

Pfizer Investigational Site, Mexico City

20000

Pfizer Investigational Site, Aguascalientes

34300

Pfizer Investigational Site, Durango

45040

Pfizer Investigational Site, Zapopan

45200

Pfizer Investigational Site, Zapopan

53100

Pfizer Investigational Site, Naucalpan

Unknown

Pfizer Investigational Site, Naucalpan Edo. de Mexico

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00468650 - A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction. | Biotech Hunter | Biotech Hunter